MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
securities
$139,291K
Net income (loss)
$31,378K
Stock-based compensation
expense
$16,056K
Other liabilities
$7,633K
Prepaid expenses, other
current assets and other...
-$780K
Depreciation and
amortization
$514K
Change in fair value of
contingent consideration
$484K
Non-cash lease expense
$149K
Amortization of debt issuance
costs
$8K
Net cash provided by
investing activities
$37,983K
Net cash provided by
(used in) operating...
$25,980K
Canceled cashflow
$101,308K
Canceled cashflow
$31,022K
Net increase
(decrease) in cash and cash...
$62,920K
Canceled cashflow
$1,043K
Purchases of marketable
securities
$101,268K
Purchases of property and
equipment
$40K
Accounts receivable
$18,931K
Accrued compensation
-$3,954K
Accounts payable
-$2,970K
Essentialis acquisition
milestone payments
$2,954K
Inventory
$1,831K
Accretion of
premium/discount on marketable...
$221K
Operating lease
liabilities
-$133K
Other non-cash
reconciling items
$28K
something is missing
$5,187K
Proceeds from exercise of
stock options
$52K
Net cash provided by
(used in) financing...
-$1,043K
Canceled cashflow
$5,239K
Proceeds from exercise of
common stock warrants
-$5,187K
Essentialis acquisition
milestone payments
$1,090K
Payment for repurchase
of common stock
$4K
Tax withholding
payments for net...
$1K
Back
Back
Cash Flow
SOLENO THERAPEUTICS INC (SLNO)
SOLENO THERAPEUTICS INC (SLNO)
source: myfinsight.com